John P. Christodouleas

Author

Also Known As

Christodouleas J, Christodouleas, John P., J Christodouleas, J christodouleas, J. Christodouleas, J. P. Christodouleas, J.P. Christodouleas, John Christodouleas, John P Christodouleas, John P. Christodouleas

754

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania The University of Texas MD Anderson Cancer Center Washington University in St. Louis Hospital of the University of Pennsylvania Johns Hopkins University

About

John P. Christodouleas is an author at University of Pennsylvania specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	1K
2	Health Sciences	6	6	293
3	General Surgery	1	1	43
4	Health Policy	1	1	18
5	Immunology	1	1	62

John P. Christodouleas

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy Sophie R. de Mol van Otterloo, John P. Christodouleas, Erwin L. A. Blezer, Frontiers in Oncology	2020	136
A moving target: Image guidance for stereotactic body radiation therapy for early-stage non-small cell lung cancer Michael N. Corradetti, Nandita Mitra, Lara P. Bonner Millar, Practical Radiation Oncology Adaptive RadiotherapyRadiation MedicineMedical ImagingRadiation TherapyMedicine	2012	120
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours Amit Maity, Rosemarie Mick, Alexander C. Huang, British Journal of Cancer	2018	101
Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy Mohamed S. Zaghloul, John P. Christodouleas, Andrew M. Smith, JAMA Surgery	2017	88
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710 John P. Christodouleas, Brian C. Baumann, Jiwei He, Cancer	2014	75
Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation Brigid A. McDonald, Sastry Vedam, Jinzhong Yang, International Journal of Radiation OncologyBiologyPhysics	2020	75
A case‐matched study of toxicity outcomes after proton therapy and intensity‐modulated radiation therapy for prostate cancer Penny Fang, Rosemarie Mick, Curtiland Deville, Cancer	2014	71
Radical Cystectomy versus Bladder-Preserving Therapy for Muscle-Invasive Urothelial Carcinoma: Examining Confounding and Misclassification Biasin Cancer Observational Comparative Effectiveness Research Justin E. Bekelman, Elizabeth A. Handorf, Thomas J. Guzzo, Value in Health Examining ConfoundingUrological ResearchUrologySurgical OncologyUrologic Cancer Epidemiology	2013	71
Bladder Cancer Patterns of Pelvic Failure: Implications for Adjuvant Radiation Therapy Brian C. Baumann, Thomas J. Guzzo, Jiwei He, International Journal of Radiation OncologyBiologyPhysics Bladder Cancer PatternsUrologyGenitourinary CancerMedicinePelvic Prolapse	2013	63
Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer Emily Feld, Joanna Harton, Neal J. Meropol, European Urology Metastatic Urothelial CancerUrologyGenitourinary CancerMedicineImmunology	2019	62

Page 1